Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In animal studies, prolactin has been found to be important for mammary epithelial development and its administration has been shown consistently to increase the rate of mammary tumor formation. Previous epidemiologic studies of prolactin and breast cancer risk in postmenopausal women have been limited in size, and the results have been inconsistent. We conducted a nested case-control study within the prospective Nurses' Health Study cohort to better determine the relationship between plasma prolactin levels and postmenopausal breast cancer risk. METHODS: Blood samples were collected from cohort members during the period from 1989 through 1990. Prolactin levels were measured by use of a microparticle enzyme immunoassay. Included in this analysis were 306 postmenopausal women who were diagnosed with breast cancer after blood donation but before June 1994. One or two postmenopausal control subjects were matched per case subject on the basis of age, postmenopausal hormone use, and time of day and month of blood collection; the study included a total of 448 control subjects. RESULTS: In conditional logistic regression analyses, a significant positive association was observed between plasma level of prolactin and postmenopausal breast cancer risk (highest versus lowest quartile, multivariate relative risk = 2.03; 95% confidence interval = 1.24-3.31; two-sided P for trend = .01). The relationship was independent of plasma sex steroid hormone levels and was similar after excluding case subjects diagnosed in the first 2 years after blood collection. CONCLUSIONS: These prospective data suggest that higher plasma prolactin levels are associated with an increased risk of breast cancer in postmenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,575
Flexible regression models with cubic splines
Durrleman, S., & Simon, R. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080504 · Cited by 2,689
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Self-citationMeasurement Error in Nonlinear Models
Carroll, R. J., Ruppert, D., & Stefanski, L. A. (1995) · Springer eBooks · doi:10.1007/978-1-4899-4477-1 · Cited by 1,749
Fundamentals of Biostatistics.
Barath, E., & Rosner, B. A. (1992) · Biometrics · doi:10.2307/2532371 · Cited by 1,183
Self-citationEndogenous Hormones and Breast Cancer Risk
Bernstein, L., & Ross, R. K. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036116 · Cited by 691
Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal Women
Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D., Barbieri, R. L., & Speizer, F. E. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1292 · Cited by 687
Self-citationCovariate measurement errors and parameter estimation in a failure time regression model
PRENTICE, R. L. (1982) · Biometrika · doi:10.1093/biomet/69.2.331 · Cited by 668
TANAKA, T., SHIU, R. P. C., GOUT, P. W., BEER, C. T., NOBLE, R. L., & FRIESEN, H. G. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-5-1058 · Cited by 571
Alcohol, Height, and Adiposity in Relation to Estrogen and Prolactin Levels in Postmenopausal Women
Hankinson, S. E., Willett, W. C., Manson, J. E., Hunter, D. J., Colditz, G. A., Stampfer, M. J., Longcope, C., & Speizer, F. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.17.1297 · Cited by 560
Self-citationProlactin and murine mammary tumorigenesis: a review.
Welsch, C. W., & Nagasawa, H. (1977) · PubMed · Cited by 508
Structural Variants of Prolactin: Occurrence and Physiological Significance
SINHA, Y. N. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-354 · Cited by 433
The Mammary gland : development, regulation, and function
Neville, M. C., & Daniel, C. W. (1987) · Plenum Press eBooks · Cited by 409
Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.
Hankinson, S. E., Manson, J. E., Spiegelman, D. L., Willett, W. C., Longcope, C., & Speizer, F. E. (1995) · PubMed · Cited by 384
Self-citationThe 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
Clapp, C., MARTIAL, J. A., Guzman, R. C., Rentier-Delure, F., & Weiner, R. I. (1993) · Endocrinology · doi:10.1210/en.133.3.1292 · Cited by 340
Prolactin synthesis and secretion by human breast cancer cells.
Ginsburg, E., & Vonderhaar, B. (1995) · PubMed · Cited by 302
Regression calibration method for correcting measurement-error bias in nutritional epidemiology
Spiegelman, D., McDermott, A., & Rosner, B. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.1179s · Cited by 254
Self-citationClevenger, C. V., Chang, W. P., Ngo, W., Pasha, T. L., Montone, K. T., & Tomaszewski, J. E. (1995) · PubMed Central · Cited by 252
Endogenous estrogen and postmenopausal breast cancer: a quantitative review
Thomas, H. V., Reeves, G. K., & Key, T. J. A. (1997) · Cancer Causes & Control · doi:10.1023/a:1018476631561 · Cited by 241
Bruning, P. F., Van Doorn, J., Bonfrèr, J. M. G., Van Noord, P. A. M., Korse, C. M., Linders, T. C., & Hart, A. A. M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620306 · Cited by 210
RESERPINE USE IN RELATION TO BREAST CANCER
Heinonen, O. P., Shapiro, S., Tuominen, L., & Turunen, M. I. (1974) · The Lancet · doi:10.1016/s0140-6736(74)93259-0 · Cited by 205
Regression Calibration in Failure Time Regression
Wang, C. Y., Hsu, L., Feng, Z. D., & Prentice, R. L. (1997) · Biometrics · doi:10.2307/2533103 · Cited by 168
Effect of transport conditions on the stability of biochemical markers in blood.
Hankinson, S. E., London, S. J., Chute, C. G., Barbieri, R. L., Jones, L., Kaplan, L. A., Sacks, F. M., & Stampfer, M. J. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.12.2313 · Cited by 137
Self-citationISHIZUKA, B., QUIGLEY, M. E., & YEN, S. S. C. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-6-1111 · Cited by 123 · cited 1×
“Circulating prolactin has a strong circadian variation (17), increases substantially with a noontime meal ( 34 ), and—postmenopausally— tends to fluctuate more over time (within a woman) than do most sex steroid hormones (21).”
BackgroundReserpine and Breast Cancer in a Retirement Community
Mack, T. M., Henderson, B. E., Gerkins, V. R., Arthur, M., Baptista, J., & Pike, M. C. (1975) · New England Journal of Medicine · doi:10.1056/nejm197506262922603 · Cited by 112
Simon, W. E., Albrecht, M. C., Trams, G., Dietel, M., & Hölzel, F. (1984) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/73.2.313 · Cited by 92
Kodlin, D., & McCarthy, N. (1978) · Cancer · doi:10.1002/1097-0142(197802)41:2<761::aid-cncr2820410250>3.0.co;2-2 · Cited by 90
Relationship of Blood Prolactin Levels and the Risk of Subsequent Breast Cancer
Wang, D. Y., Stavola, B. L. D., Bulbrook, R. D., Allen, D., Kwa, H. G., Fentiman, I. S., Hayward, J. L., & Millis, R. R. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.2.214 · Cited by 83
Bernstein, L., Ross, R. K., Pike, M. C., Brown, J. B., & Henderson, B. E. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.56 · Cited by 79
Disordered nocturnal prolactin regulation in women with breast cancer.
Malarkey, W. B., Schroeder, L., Stevens, V. C., James, A. G., & Lanese, R. R. (1977) · PubMed · Cited by 74
Cleaved Prolactin: Evidence for Its Occurrence in Human Pituitary Gland and Plasma*
Sinha, Y. N., Gilligan, T., LEE, D. W., Hollingsworth, D. R., & Markoff, E. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-2-239 · Cited by 73
Prolactin and breast cancer risk
Ingram, D. M., Nottage, E., & Roberts, A. (1990) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb126153.x · Cited by 68
MATCHED-PAIRS STUDY OF RESERPINE USE AND BREAST CANCER
LASKA, E. M., Meisner, M., Siegel, C., Fischer, S. M., & WANDERLING, J. A. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92731-2 · Cited by 65
Plasma prolactin levels in patients with breast cancer
Rose, D. P., & Pruitt, B. T. (1981) · Cancer · Cited by 53
Endogenous Sex Hormones, Prolactin, and Breast Cancer in Premenopausal Women2
Meyer, F., Brown, J. B., Morrison, A. S., & MacMahon, B. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/77.3.613 · Cited by 52
Aromaa, A., Hakama, M., Hakulinen, T. R., Saxén, E., Teppo, L., & Idänpään-Heikkilä, J. J. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910180603 · Cited by 49
RAUWOLFIA DERIVATIVES AND BREAST CANCER IN HYPERTENSIVE WOMEN
Armstrong, B. K., White, G., Skegg, D. C. G., & Doll, R. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92966-4 · Cited by 49
Haro, L. S., LEE, D. W., Singh, R. N. P., BEE, G., Markoff, E., & Lewis, U. J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-379 · Cited by 47
Secreto, G., Recchione, C., Cavalleri, A., Miraglia, M. C., & Dati, V. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.35 · Cited by 43
Reserpine and Breast Cancer: A Community-Based Longitudinal Study of 2,000 Hypertensive Women
Labarthe, D. R. (1980) · JAMA · doi:10.1001/jama.1980.03300480024019 · Cited by 36
Total prolactin binding sites in human breast cancer biopsies
Peyrat, J. P., Dewailly, D., Djiane, J., et al. (1981) · Breast Cancer Research and Treatment · doi:10.1007/bf01806753 · Cited by 29
Influence of hormones on DNA synthesis of breast tumors in culture
Calaf, G. M., Garrido, F., Moyano, C., & Rodríguez, R. (1986) · Breast Cancer Research and Treatment · doi:10.1007/bf01807335 · Cited by 21
Cited by
Cancer epidemiology in the last century and the next decade
Peto, J. (2001) · Nature · doi:10.1038/35077256 · Cited by 681
Mammographic breast density as an intermediate phenotype for breast cancer
Boyd, N. F., Rommens, J. M., Vogt, K., Lee, V., Hopper, J. L., Yaffe, M. J., & Paterson, A. D. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70390-9 · Cited by 613
The Nurses׳ Health Study: lifestyle and health among women
Colditz, G. A., & Hankinson, S. E. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1608 · Cited by 590
Self-citationThe Role of Prolactin in Mammary Carcinoma
Clevenger, C. V., Furth, P. A., Hankinson, S. E., & Schuler, L. A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0036 · Cited by 545
Self-citationUnderstanding breast cancer risk - where do we stand in 2005?
Dumitrescu, R. G., & Cotarla, I. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00350.x · Cited by 502
Metadata
- Authors
- Hankinson, S. E., Willett, W. C., Michaud, D. S., Manson, J. E., Colditz, G. A., Longcope, C., Rosner, B., & Speizer, F. E.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-04-07
- Volume
- 91
- Issue
- 7
- Pages
- 629-634
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2105028526
- Cited by
- 297
- References
- 47
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.